Published in Women's Health Weekly, April 24th, 1995
"Between 70 and 80 percent of these 'node negative' patients need no chemotherapy and, because of its inherent dangers, should avoid it. Unfortunately, the other 20 to 30 percent will certainly die without it. The difficulty, is in determining which kind of tumor a patient has."
Angiogenesis, Dr. Weidner believes, may provide pathologists with a valuable tool for predicting when chemotherapy is needed. One day, it may even provide a new avenue for slowing or halting the disease.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.